Infection with human immunodeficiency virus (HIV) is routinely and easily diagnosed with use of enzyme immunoassay (EIA) test kits. We describe an unusual patient who developed AIDS despite testing negative for antibodies to HIV 35 times over a 4-year period. HIV infection was confirmed by the results of p24-antigen assays and polymerase chain reaction amplification of proviral DNA. Sequence analysis of the virus demonstrated that it was closely related to a strain obtained from the patient's sexual partner. The explanation for this patient's persistently negative EIA results is unclear. However, this case does suggest that physicians who treat patients with AIDS-defining conditions but for whom standard HIV antibody testing is negative should consider the possibility that HIV infection is present and may be identified by additional testing procedures.
Infection with HIV has been reliably detected in infected nied any history of liver, renal, or immunosuppressive disease individuals by using EIAs approved by the U.S. Food and Drug or treatment with immunosuppressive drugs. He had traveled to Administration (FDA) in 1985 [1, 2] . The main limitation of Europe in the early 1980s, but had remained in the southwestern EIA has been its inability to detect infection in patients during United States since then. He had been employed as a constructhe ''window period'' from initial virus acquisition to the time tion worker and painter until his illness. Routine laboratory when antibodies become detectable. Otherwise, the screening tests, a chest radiograph, and another EIA for HIV were all EIAs and confirmatory western blot tests have been believed negative. The patient was discharged without a diagnosis. to be of sufficient sensitivity and specificity to be considered He was readmitted in August 1995 for evaluation of bilateral diagnostic of HIV infection [2 -6] .
pulmonary infiltrates. , but an EIA and western blot assay viously reported in part [7] .) for antibodies to HIV, which were performed by the Utah Health Department Laboratory (Salt Lake City), were again negative. Two months after this illness, the patient was readmitSee editorial response by Morens on pages 101 -3.
ted to the hospital with bacterial pneumonia and empyema. His CD4 / lymphocyte count had decreased to 69/mm 3 . The patient was married and reported sexual contact without Case Report condom use with his wife between 1989 and 1993; the couple separated in 1993 and had no further sexual contact. The wife A previously healthy 36-year-old male developed fatigue in was interviewed and reported sexual contact with a known early 1995. In April 1995, an EIA was negative for antibodies HIV-infected partner between 1984 and 1989. She reported to HIV. He was admitted to the hospital in June 1995 for that this partner had died of AIDS in 1994. She developed evaluation of a 27-lb weight loss, diarrhea, shortness of breath P. carinii pneumonia in 1994 and was found to be seropositive that worsened with exertion, nonproductive cough, fever, chills, for HIV at that time. headaches, myalgias, and right-upper-quandrant pain. He deOur patient was unaware of her diagnosis until after his hospitalization in August 1995. His only identified risk factor for HIV infection was sexual contact with his HIV-infected wife. He denied homosexual contact or receipt of a transfusion. 1990 and April 1994 at a plasmapheresis center. The records at Discussion the plasmapheresis center indicated that the patient had donated
In this report we document the case of an HIV-infected man plasma 33 times during this interval, and an EIA was negative with 35 negative EIAs for HIV. Because the time when the patient for antibodies to HIV each time.
actually became infected cannot be determined, the true number Because of the strong clinical evidence of immunosuppresof false-negative tests and the actual time line of his infection sion and the patient's history of sexual exposure to an HIVare unknown. However, these negative results clearly persisted infected individual, additional testing of samples obtained in through a period of asymptomatic infection that evolved into October 1995 and December 1995 was arranged via the Utah advanced HIV infection, with the occurrence of two separate State Health Department and performed at the Centers for Dis-AIDS-defining opportunistic infections and with CD4 / lymphoease Control and Prevention.
cyte counts indicative of severe immunosuppression. These samples were weakly reactive (signal/cutoff ratio,
The persistently seronegative status of our patient is not õ2.2) with use of an HIV-EIA test kit (Abbott Laboratories, associated with previously recognized causes. The most comNorth Chicago, IL). HIV-EIA assays with use of test kits from mon cause of negative results is testing during the window Organon Teknika (Durham, NC), and Genetics Systems (Seatperiod when seroconversion is occurring [2, 8] ; in this case, tle) were completely nonreactive (signal/cutoff ratio, õ1.0).
the patient was well past a window period and had advanced Western blot assays showed a weak gag band (p17), which infection while he was still HIV seronegative. Isolated case was considered an indeterminant result. Assays for p24 antigen reports have suggested that patients with late-stage infection were weakly reactive, but because the reactivity was not neumay lose antibodies because of overwhelming failure of the tralizable, the assay results were not clearly supportive of HIV immune system (seroreversion). However, seroreversion seems infection.
unlikely in our patient because of the prolonged duration of When subjected to base dissociation to disrupt immune comtesting before he evidenced advanced disease. On the basis of plexes, the p24-antigen results became strongly reactive and neuantibody responses to immunization, he was clearly capable of tralizable. HIV proviral DNA was also found in peripheral blood producing antibodies and should have been capable of dismononuclear cells from the patient and his wife in a nested PCR playing an antibody response to HIV. Moreover, investigators (DNA-PCR). Sequencing showed that the isolates from the patient who have studied large numbers of HIV-infected patients have and his wife differed by 7.4% over 345 nucleotides of the C2V3 failed to identify any with true seroreversions [9, 10] . region of the env gene and by 3.1% over 383 nucleotides of the There has been recent concern about the divergence of HIV p17 region of the gag gene. Construction of a phylogenetic tree strains, which may make detection of the virus with use of the demonstrated the close relationship between the HIV isolates from current kits impossible [11] . For example, group O strains of the patient and his wife, with bootstrap support of 98% and 100%, HIV are not consistently detected by EIAs designed to detect respectively, for each gene region.
HIV-1 and HIV-2 in the United States [12] . The first group O Additional information was obtained to better define the infection was identified in the United States in July 1996 [13] . patient's ability to mount an immune response. At the time Genetic analysis of our patient's virus showed a group M, that testing for antibodies to HIV was negative, an EIA for subtype B strain typical of those usually found in the United antibodies to cytomegalovirus (CMV) was positive (signal/cutStates. This strain was practically identical genetically to that off ratio, 2.33), and serology for antibodies to Epstein Barr causing a typical, HIV-antibody-positive infection in his wife. nuclear antigen was positive (titer, 1:80). Total levels of IgA, A small number of persistently seronegative HIV-infected IgG, and IgM were 393 mg/dL, 1,000 mg/dL, and 166 mg/dL, patients have been described, and this phenomenon cannot be respectively -all within normal limits in the testing laboratory.
explained [14 -16] . In these cases, disease progression was Preinoculation titers and postinoculation titers (at 1 month) rapid, and samples for testing were obtained only after the for antibodies to Corynebacterium diphtheriae and Clostridium patients became ill. Our patient has not had a rapidly progrestetani were as follows: preinoculation, 1:320 and 1:2,560; and sive clinical course and remains stable despite his episodes of postinoculation, 1:2,560 and 1:20,480, respectively.
P. carinii infection and CMV infection 6 months after his initial With respect to the possible implications for recipients of presentation. our patient's blood products, we determined that he had only Without a definite explanation for our patient's negative donated plasma at a collection facility regulated by the FDA.
antibody status, it is difficult to determine the likelihood of All of the plasma was subsequently treated with viral inactivaadditional similar cases although reports of such cases are rare. tion techniques to ensure that the plasma products were HIV The results of viral culture, p24-antigen detection, and proviral inactivated. Workers at the FDA reviewed the processing re-DNA amplification techniques have rarely demonstrated infeccords of the plasmapheresis center and determined that none tion in patients with known high-risk exposures and negative of the blood products from the patient had been transfused antibody tests [17 -20] . In the present report, we describe a without being subjected to an inactivation process. A retrospecpatient for whom standard laboratory screening failed to detect tive investigation of persons who may have received blood HIV infection but for whom p24 antigen detection and DNA-PCR established a diagnosis. products from the patient was not conducted.
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